ReviewThe Lancet. Respiratory medicine2025

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials.

Richard G White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.